- Grebe, Eduard;
- Yu, Elaine A;
- Bravo, Marjorie D;
- Welte, Alex;
- Bruhn, Roberta L;
- Stone, Mars;
- Green, Valerie;
- Williamson, Phillip C;
- Feldstein, Leora R;
- Jones, Jefferson M;
- Busch, Michael P;
- Custer, Brian
Background
To inform public health policy, it is critical to monitor coronavirus disease 2019 vaccine effectiveness (VE), including against acquiring infection.Methods
We estimated VE using self-reported vaccination in a retrospective cohort of repeat blood donors who donated during the first half of 2021, and we demonstrated a viable approach for monitoring VE via serological surveillance.Results
Using Poisson regression, we estimated an overall VE of 88.8% (95% confidence interval, 86.2-91.1), adjusted for demographic covariates and variable baseline risk.Conclusions
The time since first reporting vaccination, age, race and/or ethnicity, region, and calendar time were statistically significant predictors of incident infection.